Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.

Torino D, Mollica A, Pinnen F, Feliciani F, Spisani S, Lucente G.

Bioorg Med Chem. 2009 Jan 1;17(1):251-9. doi: 10.1016/j.bmc.2008.11.010. Epub 2008 Nov 12.

PMID:
19081258
2.

Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs.

Pagani Zecchini G, Nalli M, Mollica A, Lucente G, Paglialunga Paradisi M, Spisani S.

J Pept Res. 2002 Jun;59(6):283-91.

PMID:
12010519
3.

Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions.

Lucente G, Giordano C, Sansone A, Torino D, Spisani S.

Amino Acids. 2009 Jul;37(2):285-95. doi: 10.1007/s00726-008-0145-3. Epub 2008 Jul 18.

PMID:
18636221
4.

Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues.

Mollica A, Feliciani F, Stefanucci A, Costante R, Lucente G, Pinnen F, Notaristefano D, Spisani S.

J Pept Sci. 2012 Jun;18(6):418-26. doi: 10.1002/psc.2414. Epub 2012 Apr 24.

PMID:
22528501
5.

Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue.

Mollica A, Paradisi MP, Varani K, Spisani S, Lucente G.

Bioorg Med Chem. 2006 Apr 1;14(7):2253-65. Epub 2005 Nov 21.

PMID:
16303307
6.

Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.

Giordano C, Lucente G, Mollica A, Nalli M, Pagani Zecchini G, Paglialunga Paradisi M, Gavuzzo E, Mazza F, Spisani S.

J Pept Sci. 2004 Aug;10(8):510-23.

PMID:
15347138
7.
8.

Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues.

Ferretti ME, Nalli M, Biondi C, Colamussi ML, Pavan B, Traniello S, Spisani S.

Cell Signal. 2001 Apr;13(4):233-40.

PMID:
11306240
9.

Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe.

Zecchini GP, Paradisi MP, Torrini I, Nalli M, Lucente G, Spisani S.

Farmaco. 2000 Apr;55(4):308-13.

PMID:
10966163
10.

Chemotactic peptide analogues. Synthesis and chemotactic activity of N-formyl-Met-Leu-Phe analogues containing (S)-phenylalaninol derivatives.

Zecchini GP, Paradisi MP, Torrini I, Spisani S.

Arch Pharm (Weinheim). 1995 Sep;328(9):673-6.

PMID:
7487425
11.

New fMLF-OMe analogues containing constrained mimics of phenylalanine residue.

Torrini I, Mastropietro G, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Spisani S.

Arch Pharm (Weinheim). 1998 May;331(5):170-6.

PMID:
9691248
12.

Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing beta-alanine or taurine at the central position.

Giordano C, Lucente G, Nalli M, Pagani Zecchini G, Paglialunga Paradisi M, Varani K, Spisani S.

Farmaco. 2003 Nov;58(11):1121-30.

PMID:
14572863
13.

Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.

Pagani Zecchini G, Torrini I, Paglialunga Paradisi M, Lucente G, Spisani S.

Farmaco. 1994 Nov;40(11):739-42.

PMID:
7832975
14.

An evaluation of fMLP pocket dimensions and features using formyltetrapeptides.

Cavicchioni G, Varani K, Niccoli S, Rizzuti O, Spisani S.

J Pept Res. 1999 Oct;54(4):336-43.

PMID:
10532239
15.

Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety.

Torrini I, Paglialunga Paradisi M, Pagani Zecchini G, Lucente G, Mastropietro G, Spisani S.

J Pept Res. 2000 Feb;55(2):102-9.

PMID:
10784026
16.

Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.

Giordano C, Lucente G, Masi A, Paglialunga Paradisi M, Sansone A, Spisani S.

Amino Acids. 2007 Sep;33(3):477-87. Epub 2006 Oct 6.

PMID:
17021652
17.

Hybrid alpha/beta-peptides: for-Met-Leu-Phe-OMe analogues containing geminally disubstituted beta2,2- and beta 3,3-amino acids at the central position.

Mollica A, Paglialunga Paradisi M, Torino D, Spisani S, Lucente G.

Amino Acids. 2006 Jun;30(4):453-9. Epub 2006 Mar 20.

PMID:
16547648
18.

Chemotactic peptide analogues. Centrally constrained chemotactic N-formyltripeptides: synthesis, conformation, and activity of two new analogues.

Pagani Zecchini G, Paglialunga Paradisi M, Torrini I, Lucente G, Mastropietro G, Paci M, Spisani S.

Arch Pharm (Weinheim). 1996 Dec;329(12):517-23.

PMID:
9038418
19.

The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.

Cavicchioni G, Breveglieri A, Boggian M, Vertuani G, Reali E, Spisani S.

J Pept Sci. 1996 May-Jun;2(3):135-40.

PMID:
9231322
20.

Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.

Lucente G, Paradisi MP, Giordano C, Sansone A, Torino D, Spisani S.

Amino Acids. 2008 Aug;35(2):329-38. Epub 2007 Dec 28.

PMID:
18163179

Supplemental Content

Support Center